Maintenance of telomere length in AML

Area of Science:

• Molecular Biology
• Oncology
• Genetics

Background:

• Telomere length is critical for cellular aging and cancer development.
• Telomere dysfunction and mutations in telomerase genes (TERC, TERT) are implicated in various cancers.
• Accurate telomere length and telomerase activity data in specific cancer types, like acute myeloid leukemia (AML), are challenging to obtain.

Purpose of the Study:

• To review the fundamental aspects of telomere biology.
• To elucidate the involvement of telomere function, telomerase activity, and TERC/TERT mutations in bone marrow failure and leukemias.
• To discuss the puzzling situation in AML and the implications of telomere crisis in cancer progression.

Main Methods:

• Literature review of telomere biology and cancer research.
• Analysis of telomere length and telomerase activity in various cancers, including AML and chronic myeloid leukemia (CML).
• Examination of genetic mutations (TERT promoter, TERT gene amplification) and their impact on telomere length and cancer development.

Main Results:

• Most cancers show increased telomerase levels post-'telomere crisis,' often linked to poor prognosis and defective DNA damage response.
• AML cells typically have shorter telomeres than normal leukocytes but often lack signs of 'telomere crisis.'
• In CML, telomere length differences correlate with disease progression, indicating a ticking mitotic clock and impending 'telomere crisis.' Very short telomeres predict progression in CLL, myeloma, and solid tumors.

Conclusions:

• Telomere length and telomerase activity are key factors in cancer development and progression.
• The concept of 'telomere crisis' is important for understanding cancer prognosis and evolution.
• Longitudinal studies of telomere length in AML are recommended to clarify its role in the disease.